Factors affecting glomerular filtration rate, as measured by iohexol disappearance, in men with or at risk for HIV infection

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Margolick, Joseph B ^a   Jacobson, Lisa P ^a   Schwartz, George J ^b   Abraham, Alison G ^a   Darilay, Annie T ^a   Kingsley, Lawrence A ^c   Witt, Mallory D ^d,e   Palella Jr , Frank J ^f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IOHEXOL; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGING; ARTICLE; CD4+ T LYMPHOCYTE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS FILTRATION RATE; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEN WHO HAVE SEX WITH MEN; NEGRO; RACE DIFFERENCE; RISK FACTOR; TREATMENT DURATION; COMPLICATION; HIV INFECTIONS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC;

ADULT; ANTI-RETROVIRAL AGENTS; CROSS-SECTIONAL STUDIES; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; IOHEXOL; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC;

EID: 84895513546     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086311     Document Type: Article

References (49)

1. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338: 853-860. (Pubitemid 28135961)
2. Hogg R, Lima V, Sterne JA, Grabar S, Battegay M, et al. (2008) Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372: 266-267.
3. Adih WK, Selik RM, Hu X (2010) Trends in diseases reported on US death certificates that mentioned HIV infection. J Int Assoc Physicians AIDS Care 1996-2006.
4. Belloso WH, Orellana LC, Grinsztejn B, Madero JS, La RA, et al. (2010) Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites. HIV Med 11: 554-564. HIV824 [pii];10.1111/j.1468-1293.2010.00824.x [doi].
5. Wever K, van Agtmael MA, Carr A (2010) Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men. J Acquir Immune Defic Syndr 55: 78-81. 10.1097/QAI.0b013e3181d05579 [doi].
6. Mocroft A, Kirk O, Reiss P, De WS, Sedlacek D, et al. (2010) Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS 24: 1667-1678. 10.1097/QAD.0b013e328339fe53 [doi].
7. Rodriguez-Novoa S, Alvarez E, Labarga P, Soriano V (2010) Renal toxicity associated with tenofovir use. Expert Opin Drug Saf 9: 545-559. 10.1517/14740331003627458 [doi].
8. Labarga P, Barreiro P, Martin-Carbonero L, Rodriguez-Novoa S, Solera C, et al. (2009) Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. AIDS 23: 689-696. 10.1097/QAD.0b013e3283262a64 [doi].
9. Judd A, Boyd KL, Stohr W, Dunn D, Butler K, et al. (2010) Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study. AIDS 24: 525-534. 10.1097/QAD.0b013e3283333680 [doi].
10. Masia M, Enriquez R, Sirvent A, Gutierrez F (2010) Severe acute renal failure associated with rhabdomyolysis during treatment with raltegravir. A call for caution. J Infect 61: 189-190. S0163-4453(10)00131-3 [pii];10.1016/j.jinf. 2010.04.011 [doi].
11. Cockroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41.
12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470. 199903160-00002 [pii].
13. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, et al. (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20-29. 10.1056/NEJMoa1114248 [doi].
14. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AFI, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Int Med 150: 604-612.
15. Bonjoch A, Bayes B, Riba J, Puig J, Estany C, et al. (2010) Validation of estimated renal function measurements compared with the isotopic glomerular filtration rate in an HIV-infected cohort. Antiviral Res 88: 347-354. S0166-3542(10)00737-0 [pii];10.1016/j.antiviral.2010.09.015 [doi].
16. Vrouenraets SM, Fux CA, Wit FW, Garcia EF, Brinkman K, et al. (2012) A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function. Clin Nephrol 77: 311-320. 9199 [pii].
17. Inker LA, Wyatt C, Creamer R, Hellinger J, Hotta M, et al. (2012) Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. J Acquir Immune Defic Syndr 61: 302-309. 10.1097/QAI.0b013e31826a6c4f [doi].
18. Praditpornsilpa K, Avihingsanon A, Chaiwatanarat T, Chaiyahong P, Wongsabut J, et al. (2012) Comparisons between validated estimated glomerular filtration rate equations and isotopic glomerular filtration rate in HIV patients. AIDS 26: 1781-1788. 10.1097/QAD.0b013e328356480d [doi].
19. Wyatt CM, Schwartz GJ, Owino OW, Abuya J, Abraham AG, et al. (2013) Estimating Kidney Function in HIV-Infected Adults in Kenya: Comparison to a Direct Measure of Glomerular Filtration Rate by Iohexol Clearance. PLoS ONE 8: e69601. 10.1371/journal.pone.0069601 [doi];PONE-D-13-07026 [pii].
20. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, et al. (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254. (Pubitemid 46768608)
21. Gaspari F, Perico N, Ruggenenti P, Mosconi L, Amuchastegui CS, et al. (1995) Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 6: 257-263.
22. Krutzén E, Back SE, Nilsson-Ehle I (1984) Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration. J Lab Clin Med 104,955-961. (Pubitemid 15091139)
23. Brown SC, O'Reilly PH (1991) Iohexol clearance for the determination of glomerular filtration rate in clinical practice: evidence for a new gold standard. J Urol 146: 675-679.
24. Rahn KH, Heidenreich S, Bruckner D (1999) How to assess glomerular function and damage in humans. J Hypertens 17: 309-317. (Pubitemid 29116637)
25. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, et al. (1987) The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 126: 310-318. (Pubitemid 17102758)
26. Dudley J, Jim S, Hoover D, Metz S, Thackerey R, et al. (1995) The Multicenter AIDS Cohort Study: retention after 9 1/2 years. Am J Epidemiol 142: 323-330.
27. Silvestre AJ, Hylton JB, Johnson LM, Houston C, Witt M, et al. (2006) Recruiting minority men who have sex with men for HIV research: results from a 4-city campaign. Am J Public Health 96: 1020-1027. (Pubitemid 43825268)
28. Caliendo AM, Valsamakis A, Zhou Y, Yen-Lieberman B, Andersen J, et al. (2006) Multilaboratory comparison of hepatitis C virus viral load assays. J Clin Microbiol 44: 1726-1732. 44/5/1726 [pii];10.1128/JCM.44.5.1726-1732.2006 [doi].
29. Falade-Nwulia O, Seaberg EC, Rinaldo CR, Badri S, Witt M, et al. (2012) Comparative risk of liver-related mortality from chronic hepatitis B versus chronic hepatitis C virus infection. Clin Infect Dis 55: 507-513. cis432 [pii];10.1093/cid/cis432 [doi].
30. Hultin LE, Menendez FA, Hultin PM, Jamieson BD, O'Gorman MR, et al. (2007) Assessing immunophenotyping performance: proficiency-validation for adopting improved flow cytometry methods. Cytometry B Clin Cytom 72: 249-255. (Pubitemid 46986453)
31. Schwartz GJ, Kwong T, Erway B, Warady B, Sokoll L, et al. (2009) Validation of creatinine assays utilizing HPLC and IDMS traceable standards in sera of children. Pediatr Nephrol 24: 113-119. 10.1007/s00467-008-0957-0 [doi].
32. Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, et al. (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20: 629-637. ASN.2008030287 [pii];10.1681/ASN.2008030287 [doi].
33. Schwartz GJ, Furth S, Cole SR, Warady B, Munoz A (2006) Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children. Kidney Int 69: 2070-2077. (Pubitemid 43924273)
34. Ng DK, Schwartz GJ, Jacobson LP, Palella FA, Margolick JB, et al. (2011) Universal GFR determination based on two time points during plasma iohexol disappearance. Kidney International 80: 423-430.
35. Abraham AG, Munoz A, Furth SL, Warady B, Schwartz GJ (2011) Extracellular volume and glomerular filtration rate in children with chronic kidney disease. Clin J Am Soc Nephrol 6: 741-747. CJN.08020910 [pii];10.2215/CJN.08020910 [doi].
36. Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 93: 62-66. (Pubitemid 8351870)
37. CDC (1992) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41: 1-19.
38. DHHS (2008) Guidelines for the use of antiretroviral agents among HIV-infected adults and adolescents. Available: http://aidsinfo nih gov/guidelines/.
39. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266. S0272638602093563 [pii].
40. Milliken GA, Johnson DE (2002) Analysis of Messy Data: Volume III: Analysis of Covariance. Boca Raton: Chapman & Hall/CRC.
41. Melsom T, Mathisen UD, Ingebretsen OC, Jenssen TG, Njolstad I, et al. (2011) Impaired fasting glucose is associated with renal hyperfiltration in the general population. Diabetes Care 34: 1546-1551. dc11-0235 [pii];10.2337/dc11- 0235 [doi].
42. Fehrman-Ekholm I, Kvarnstrom N, Softeland JM, Lennerling A, Rizell M, et al. (2011) Post-nephrectomy development of renal function in living kidney donors: a cross-sectional retrospective study. Nephrol Dial Transplant 26: 2377-2381. gfr161 [pii];10.1093/ndt/gfr161 [doi].
43. Barlovic DP, Zaletel J, Prezelj J (2009) Adipocytokines are associated with renal function in patients with normal range glomerular filtration rate and type 2 diabetes. Cytokine 46: 142-145. S1043-4666(09)00018-0 [pii];10.1016/j.cyto.2009.01.001 [doi].
44. Sterner G, Frennby B, Mansson S, Nyman U, Van WD, et al. (2008) Determining 'true' glomerular filtration rate in healthy adults using infusion of inulin and comparing it with values obtained using other clearance techniques or prediction equations. Scand J Urol Nephrol 42: 278-285. 783046369 [pii];10.1080/00365590701701806 [doi].
45. Butt AA, Wang X, Fried LF (2011) HCV infection and the incidence of CKD. Am J Kidney Dis 57: 396-402. S0272-6386(10)01446-0 [pii];10.1053/j.ajkd.2010.09. 023 [doi].
46. Perico N, Cattaneo D, Bikbov B, Remuzzi G (2009) Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4: 207-220. CJN.03710708 [pii];10.2215/CJN.03710708 [doi].
47. Lindeman RD, Tobin J, Shock NW (1985) Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33: 278-285. (Pubitemid 15087125)
48. Botev R, Mallie JP, Couchoud C, Schuck O, Fauvel JP, et al. (2009) Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance. Clin J Am Soc Nephrol 4: 899-906. CJN.05371008 [pii];10.2215/CJN.05371008 [doi].
49. Gaspari F, Ruggenenti P, Porrini E, Motterlini N, Cannata A, et al. (2013) The GFR and GFR decline cannot be accurately estimated in type 2 diabetics. Kidney Int 84: 164-173. ki201347 [pii];10.1038/ki.2013.47 [doi].